Literature DB >> 4204606

Antigenicity of reduced and alkylated Australia antigen.

M Imai, A Goto, K Nishioka, S Kurashina, Y Miyakawa.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4204606

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

Authors:  J A Waters; M Kennedy; P Voet; P Hauser; J Petre; W Carman; H C Thomas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

3.  Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.

Authors:  M W Steward; B M Sisley; C Stanley; S E Brown; C R Howard
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 4.  The nature of the hepatitis B virus and its mode of replication.

Authors:  C R Howard
Journal:  Springer Semin Immunopathol       Date:  1981-04

5.  Haemagglutination inhibition assay of the common determinants and subspecificities of Australia antigen.

Authors:  M Imai; Y Yamashita; Y Miyakawa; M Mayumi
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

6.  Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.

Authors:  A P Huovila; A M Eder; S D Fuller
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

Review 7.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.